Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Its targeted mechanism makes it a valuable tool for researchers studying enzyme-driven metabolic regulation, pathway efficiency, and integrated cellular energy systems
Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
Our team of highly experienced professionals is committed to providing a supportive and welcoming atmosphere for those seeking to make positive changes in their lives
Journal of Nutritional Biochemistry, 24(3), 207213
Oral Administration (if applicable): For oral formulations of AOD-9604 , research has shown bioavailability of approximately 40% in animal studies
It achieves this by inhibiting the activity of Acetyl-CoA carboxylase, an essential enzyme in the fatty acid synthesis pathway
US$ 28.30
US$ 23.07
US$ 20.91
US$ 26.38
US$ 20.65
US$ 21.99
US$ 22.02